US Stock MarketDetailed Quotes
TSBX Turnstone Biologics
- 0.500
- +0.009+1.85%
Close Nov 26 16:00 ET
- 0.500
- 0.0000.00%
Post 20:01 ET
11.57MMarket Cap-155P/E (TTM)
0.536High0.481Low89.06KVolume0.490Open0.491Pre Close45.76KTurnover0.63%Turnover RatioLossP/E (Static)23.13MShares5.75052wk High0.27P/B7.05MFloat Cap0.43952wk Low--Dividend TTM14.09MShs Float13.200Historical High--Div YieldTTM11.18%Amplitude0.439Historical Low0.513Avg Price1Lot Size
Turnstone Biologics Key Stats
Quarterly+Annual
YOY
| (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | 6.44%-17.58M | -8.40%-15.93M | -1.69%-17.46M | 6.91%-66.15M | 20.52%-15.5M | -56.39%-18.79M | 36.36%-14.69M | -4.35%-17.17M | -55.74%-71.06M | -19.51M |
| Net income from continuing operations | 1.66%-17.03M | 0.91%-21.3M | -28,966.18%-19.63M | -79.02%-55.2M | -20.36%-16.45M | -7.23%-17.32M | -285.34%-21.5M | 100.54%68K | -192.68%-30.83M | ---13.67M |
| Operating gains losses | ---- | ---- | 47.37%-20K | --324K | --0 | --338K | --24K | ---38K | ---- | ---- |
| Depreciation and amortization | -29.86%491K | -31.78%498K | -28.21%509K | -28.27%2.8M | -44.39%659K | -34.76%700K | -21.67%730K | -0.28%709K | 180.65%3.9M | --1.19M |
| Other non cash items | 41.72%-373K | -180.19%-594K | -208.98%-791K | -2,001.02%-2.06M | -292.98%-951K | -1,900.00%-640K | -416.42%-212K | -334.86%-256K | -108.42%-98K | ---242K |
| Change In working capital | 62.85%-1.41M | -11.15%4.38M | 107.12%1.37M | 69.08%-17.92M | 102.23%211K | -5.43%-3.8M | 112.67%4.93M | -222.78%-19.26M | 32.41%-57.97M | ---9.48M |
| -Change in receivables | --0 | --0 | -95.43%194K | 523.94%8.53M | 100.54%23K | -97.20%33K | 1,656.43%4.23M | 396.49%4.25M | 14.92%-2.01M | ---4.29M |
| -Change in prepaid assets | 91.28%-257K | 52.73%1.12M | 243.75%115K | 316.24%426K | 231.39%2.72M | -179.93%-2.95M | 256.41%732K | 94.05%-80K | 92.62%-197K | ---2.07M |
| -Change in payables and accrued expense | -111.02%-1.61M | 693.78%3.19M | 125.64%676K | -207.13%-4.52M | -204.24%-1.52M | 69.06%-762K | 6,600.00%402K | -452.83%-2.64M | -179.65%-1.47M | --1.46M |
| -Change in other current assets | 380.58%495K | 129.90%125K | 336.81%431K | -373.72%-1.5M | -152.21%-1M | -84.79%103K | ---418K | ---182K | --548K | --1.92M |
| -Change in other current liabilities | 81.39%-43K | -194.44%-53K | 96.62%-44K | 10.37%-1.56M | 98.27%-6K | 74.53%-231K | 94.75%-18K | -842.03%-1.3M | -175.83%-1.74M | ---347K |
| -Change in other working capital | ---- | ---- | ---- | 63.64%-19.31M | --0 | --0 | --0 | -297.08%-19.31M | 35.20%-53.1M | ---6.16M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | 6.44%-17.58M | -8.40%-15.93M | -1.69%-17.46M | 6.91%-66.15M | 20.52%-15.5M | -56.39%-18.79M | 36.36%-14.69M | -4.35%-17.17M | -55.74%-71.06M | ---19.51M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 157.38%24.25M | 536.67%18.94M | -14.58%14.1M | -88.14%-28.09M | -191.47%-5.31M | -146.46%-42.26M | 203.80%2.98M | 2,398.05%16.5M | -346.00%-14.93M | 5.8M |
| Net PPE purchase and sale | 100.37%1K | -70.21%-80K | 80.80%-144K | 84.58%-797K | 366.67%272K | 88.21%-272K | 97.81%-47K | -22.35%-750K | -51.79%-5.17M | ---102K |
| Net investment purchase and sale | 157.75%24.25M | 529.42%19.02M | -17.46%14.24M | -179.61%-27.3M | -194.49%-5.58M | -182.96%-41.99M | 520.31%3.02M | 16,528.57%17.25M | -16,931.03%-9.76M | --5.9M |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 157.38%24.25M | 536.67%18.94M | -14.58%14.1M | -88.14%-28.09M | -191.47%-5.31M | -146.46%-42.26M | 203.80%2.98M | 2,398.05%16.5M | -346.00%-14.93M | --5.8M |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | -99.92%59K | 81.95%-48K | 0 | 3,000.83%77.05M | -3,480.00%-169K | 2,885.34%78.3M | -290.00%-266K | -8,250.00%-815K | -103.32%-2.66M | 5K |
| Net common stock issuance | ---- | ---- | ---- | --77.84M | ---179K | ---- | ---- | ---- | --0 | --0 |
| Cash dividends paid | --0 | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
| Proceeds from stock option exercised by employees | --0 | 1,366.67%44K | --0 | -33.12%105K | 100.00%10K | 350.00%9K | -97.86%3K | 730.00%83K | -53.69%157K | --5K |
| Net other financing activities | ---- | ---- | ---- | 68.08%-898K | --0 | --269K | ---269K | ---898K | ---2.81M | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | -99.92%59K | 81.95%-48K | --0 | 3,000.83%77.05M | -3,480.00%-169K | 2,885.34%78.3M | -290.00%-266K | -8,250.00%-815K | -103.32%-2.66M | --5K |
| Net cash flow | ||||||||||
| Beginning cash position | -19.08%17.52M | -56.74%14.55M | -48.98%17.91M | -71.63%35.11M | -20.33%38.89M | -73.21%21.65M | -68.45%33.63M | -71.63%35.11M | 33.39%123.76M | --48.82M |
| Current changes in cash | -60.96%6.73M | 124.77%2.97M | -126.60%-3.37M | 80.60%-17.2M | -53.09%-20.98M | 153.94%17.25M | 53.58%-11.98M | 91.35%-1.49M | -386.18%-88.65M | ---13.7M |
| End cash Position | -37.65%24.25M | -19.08%17.52M | -56.74%14.55M | -48.98%17.91M | -48.98%17.91M | -20.33%38.89M | -73.21%21.65M | -68.45%33.63M | -71.63%35.11M | --35.11M |
| Free cash flow | 7.72%-17.58M | -8.30%-16.03M | 2.47%-17.6M | 11.58%-67.4M | 20.94%-15.5M | -32.99%-19.05M | 41.34%-14.8M | -5.75%-18.05M | -55.46%-76.23M | ---19.61M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
% Chg
No Data